Mirum Pharmaceuticals Inc...

45.99
-0.09 (-0.20%)
At close: Mar 28, 2025, 3:59 PM
45.99
0.00%
After-hours: Mar 28, 2025, 04:05 PM EDT

Mirum Pharmaceuticals Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue 336.89M 186.37M 77.06M 19.14M n/a n/a n/a
Cost of Revenue 81.64M 47.04M 12.37M 1.9M 623K 324K n/a
Gross Profit 255.25M 139.34M 64.69M 17.23M -623K -324K n/a
Operating Income -87.61M -109.15M -131.22M -173.41M -104.3M -54.74M -2.92M
Interest Income 13.79M 13.73M 3.86M 366K 1.56M 2.23M 87K
Pretax Income -86.91M -162.42M -142.07M -83.95M -103.26M -52.53M -17.35M
Net Income -87.94M -163.41M -135.66M -83.99M -103.27M -52.55M -17.35M
Selling & General & Admin 202.22M 145.88M 89.07M 59.22M 22.69M 11.75M 585K
Research & Development 140.63M 102.61M 106.84M 131.43M 81.61M 42.99M 2.33M
Other Expenses n/a n/a 365K 107.42M -192K -21K n/a
Operating Expenses 342.85M 248.49M 195.91M 190.65M 104.3M 54.74M 2.92M
Interest Expense 14.31M 15.11M 15.98M 17.59M 335K n/a n/a
Selling & Marketing Expenses n/a 6.3M 72.11M 9.2M n/a n/a -292.5K
Cost & Expenses 424.49M 295.53M 208.28M 192.55M 104.3M 54.74M 2.92M
Income Tax 1.03M 991K -6.41M 37K 6K 21K -4.37M
Shares Outstanding (Basic) 47.52M 40.89M 33.84M 30.32M 25.25M 22.99M 22.99M
Shares Outstanding (Diluted) 47.52M 40.89M 33.84M 30.32M 25.25M 22.99M 22.99M
EPS (Basic) -1.85 -4 -4.01 -2.77 -4.09 -2.29 -0.75
EPS (Diluted) -1.85 -4 -4.01 -2.77 -4.09 -2.29 -0.75
EBITDA -48.97M -136.49M -122.41M -65.39M -102.31M -52.21M -17.33M
Depreciation & Amortization 23.63M 10.83M 3.68M 975K 623K 324K 4.37M